GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06566547 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06566547
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-26
- Primary completion
- 2027-05-12
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.